Biotech company Rakuten Aspyrian pulls in $134 mln

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies, has raised $134 million in financing. The investors include the SBI Group, Japan and Rakuten Inc.

North AmericaUSHealthcareBriefs